{"protocolSection":{"identificationModule":{"nctId":"NCT02849613","orgStudyIdInfo":{"id":"38RC15.337"},"organization":{"fullName":"University Hospital, Grenoble","class":"OTHER"},"briefTitle":"Regenerative Stem Cell Therapy for Stroke in Europe","officialTitle":"Regenerative Stem Cell Therapy for Stroke in Europe","acronym":"RESSTORE"},"statusModule":{"statusVerifiedDate":"2016-07","overallStatus":"WITHDRAWN","whyStopped":"Not authorized by Regulatory agencies - new protocol phase 1a in progress","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-03"},"primaryCompletionDateStruct":{"date":"2017-09","type":"ACTUAL"},"completionDateStruct":{"date":"2017-09","type":"ACTUAL"},"studyFirstSubmitDate":"2016-07-06","studyFirstSubmitQcDate":"2016-07-26","studyFirstPostDateStruct":{"date":"2016-07-29","type":"ESTIMATED"},"lastUpdateSubmitDate":"2021-09-28","lastUpdatePostDateStruct":{"date":"2021-10-06","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Grenoble","class":"OTHER"},"collaborators":[{"name":"Horizon 2020 - European Commission","class":"OTHER"},{"name":"University Grenoble Alps","class":"OTHER"},{"name":"Servicio Madrileño de Salud, Madrid, Spain","class":"OTHER"},{"name":"St. Anne's University Hospital Brno, Czech Republic","class":"OTHER"},{"name":"Andaluz Health Service","class":"OTHER_GOV"},{"name":"University of Glasgow","class":"OTHER"},{"name":"University of Eastern Finland","class":"OTHER"},{"name":"Etablissement Français du Sang","class":"OTHER"},{"name":"Tampere University","class":"OTHER"},{"name":"Histocell SL, Spain","class":"UNKNOWN"},{"name":"Medfiles CRO, Finland","class":"UNKNOWN"},{"name":"Institut National de la Santé Et de la Recherche Médicale, France","class":"OTHER_GOV"},{"name":"Hospices Civils de Lyon","class":"OTHER"},{"name":"Association Groupe ESSEC","class":"OTHER"},{"name":"NOVADISCOVERY SAS, France","class":"UNKNOWN"},{"name":"Finovatis","class":"OTHER"},{"name":"Centre Hospitalier Universitaire de Besancon","class":"OTHER"},{"name":"Assistance Publique - Hôpitaux de Paris","class":"OTHER"},{"name":"University Hospital, Toulouse","class":"OTHER"},{"name":"University Hospital, Bordeaux","class":"OTHER"},{"name":"University Hospital, Caen","class":"OTHER"},{"name":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","class":"OTHER"},{"name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","class":"OTHER"},{"name":"Servicio de Salud de Castilla La Mancha, Albacete, Spain","class":"UNKNOWN"},{"name":"Servizo Galego de Saude, Santiago de Compostela, Spain","class":"UNKNOWN"},{"name":"Pirkanmaa Hospital District, Tampere, Finland","class":"UNKNOWN"},{"name":"Hospital Vall d'Hebron","class":"OTHER"},{"name":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life.","detailedDescription":"RESSTORE European multicentre randomised phase IIb will explore the efficacy (functional recovery) and safety of intravenous infusion of allogenic adipose tissue derived mesenchymal stem cells (ADSC) in 400 stroke patients. Therapeutic effects of ADSCs will be assessed and monitored in patients using clinical rating scales, multimodal MRI and blood biomarkers.\n\nThe European regenerative therapy capacities (France, Spain, Finland, United Kingdom and Czech Republic), developed in RESSTORE will cover the full value chain in the field (large scale GMP cell production, clinical testing, biomarkers discovery, understanding of the restoring mechanisms, biobanking...)."},"conditionsModule":{"conditions":["Stroke"],"keywords":["cell therapy","stem cell","transplantation","graft","recovery","repair","stroke","mesenchymal stem cell","regenerative"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2","PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Adipose derived Stem Cells ADSC","type":"EXPERIMENTAL","description":"ADSC, single IV, 1.106 cells/kg","interventionNames":["Other: Adipose Derived Stem Cells"]},{"label":"Vehicle media","type":"SHAM_COMPARATOR","description":"IV infusion of cell excipients, 1ml/kg","interventionNames":["Other: Vehicle media"]}],"interventions":[{"type":"OTHER","name":"Adipose Derived Stem Cells","armGroupLabels":["Adipose derived Stem Cells ADSC"],"otherNames":["ADSC"]},{"type":"OTHER","name":"Vehicle media","armGroupLabels":["Vehicle media"],"otherNames":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Between-group difference of NIHSS (stroke severity score)","timeFrame":"6 months after stroke onset"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Hemispheric ischemic stroke (\\>1.5cm)\n* Inclusion from 1 to 4 days post-stroke\n* NIHSS \\> or = 7\n* No craniectomy\n* Able to follow a rehabilitation program\n* Modified Rankin scale = 0 before stroke onset\n\nExclusion Criteria:\n\n* Coma\n* Severe leucoariosis\n* Previous stroke\n* Active endocarditis, pneumonia, AIDS, active hepatic disease due to HBV or HCV\n* History of cancer\n* Pregnancy, breast feeding","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Olivier DETANTE, MD PhD","affiliation":"University Hospital Grenoble-Alpes, France","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Exuperio DIEZ TEJEDOR, MD PhD","affiliation":"La Paz University Hospital, Madrid, Spain","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University Grenoble Hospital / EFS","city":"Grenoble","zip":"38043","country":"France","geoPoint":{"lat":45.16667,"lon":5.71667}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}